Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 14 EU countries
White Paper: Evidence requirements for medical devices in the regional HTA program in Italy
Get insights from MTRC White Papers to advance your understanding of five rapid HTA reports from the Tuscany region
Recent news and posts
Rapid HTAs of five medical devices released in Tuscany in May 2026
Tuscany remains the most active Italian region in conducting HTA for medical devices, with HTA-based recommendations influencing regional adoption and procurement decisions.
Under Regional Decree No. 9122 of April 28, 2026, the Tuscany Regional Healthcare Authority released five new rapid HTA reports on May 4, 2026. The assessed technologies covered the cardiovascular and gastrointestinal endoscopy areas.
Examples of devices that received favorable recommendations include:
- Occlutech Paravalvular Leak Device (PLD) by Occlutech, intended for the closure of paravalvular leaks;
- SX-Ella Biodegradable Esophageal Stent BD by ELLA-CS, indicated for the treatment of benign esophageal strictures.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.